SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001185185-13-000934
Filing Date
2013-04-26
Accepted
2013-04-26 08:55:23
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 medizone10q033113.htm 10-Q 322396
2 ex31-1.htm EX-31.1 10327
3 ex31-2.htm EX-31.2 10155
4 ex32-1.htm EX-32.1 5168
5 ex32-2.htm EX-32.2 5227
  Complete submission text file 0001185185-13-000934.txt   2269385

Data Files

Seq Description Document Type Size
6 mzei-20130331.xml EX-101.INS 230813
7 mzei-20130331.xsd EX-101.SCH 29446
8 mzei-20130331_cal.xml EX-101.CAL 22824
9 mzei-20130331_def.xml EX-101.DEF 145379
10 mzei-20130331_lab.xml EX-101.LAB 210559
11 mzei-20130331_pre.xml EX-101.PRE 148135
Mailing Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965
Business Address 4000 BRIDGEWAY SUITE 401 SAUSALITO CA 94965 (415) 331-0303
MEDIZONE INTERNATIONAL INC (Filer) CIK: 0000753772 (see all company filings)

IRS No.: 870412648 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 002-93277-D | Film No.: 13784933
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries